Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1175-1177
Number of pages	3
Journal	Journal of the National Cancer Institute
Volume	88
Issue number	17
DOIs	https://doi.org/10.1093/jnci/88.17.1175
State	Published - 1996

ASJC Scopus subject areas

@article{e7b0a780222a4655aaea1ba9b4186c16,

title = "Combined-modality therapy for unresectable, stage III non-small-cell lung cancer - Caveat emptor or caveat venditor?",

author = "Johnson, {D. H.}",

year = "1996",

doi = "10.1093/jnci/88.17.1175",

language = "English (US)",

volume = "88",

pages = "1175--1177",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",